Press Release: 3D Bio : 3DBio Therapeutics, Inc. Strengthens Board of Directors, Welcomes Scott Dylla, Ph.D.
NEW YORK, Oct. 30, 2020 /PRNewswire/ -- 3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced Scott Dylla, Ph.D has joined its Board of Directors. Dr. Dylla is the co-founder and former Chief Scientific Officer of Stemcentrx,...
Read full article »
3DBio is a regenerative medicine company solving medical challenges with custom-engineered 3D-bioprinted living implants.
Read more